These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 7728750

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines.
    Li CY, Nagasawa H, Dahlberg WK, Little JB.
    Oncogene; 1995 Nov 02; 11(9):1885-92. PubMed ID: 7478618
    [Abstract] [Full Text] [Related]

  • 4. Cytogenetic damage and the radiation-induced G1-phase checkpoint.
    Gupta N, Vij R, Haas-Kogan DA, Israel MA, Deen DF, Morgan WF.
    Radiat Res; 1996 Mar 02; 145(3):289-98. PubMed ID: 8927696
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.
    McIlwrath AJ, Vasey PA, Ross GM, Brown R.
    Cancer Res; 1994 Jul 15; 54(14):3718-22. PubMed ID: 8033090
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F, Bay JO, Dionet C, Verrelle P.
    Bull Cancer; 1999 Apr 15; 86(4):345-57. PubMed ID: 10341340
    [Abstract] [Full Text] [Related]

  • 9. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control.
    Strunz AM, Peschke P, Waldeck W, Ehemann V, Kissel M, Debus J.
    Int J Radiat Biol; 2002 Aug 15; 78(8):721-32. PubMed ID: 12194756
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D, Goi K, Mizutani S, Yamada T, Aiello A, Fontanella E, Lamorte G, Iwata S, Ishioka C, Krajewski S, Reed JC, Pierotti MA.
    Oncogene; 1997 May 08; 14(18):2137-47. PubMed ID: 9174049
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis and cell cycle-specific change in expression of p53 in normal lymphocytes and MOLT-4 leukemic cells by nitrogen mustard.
    Bhatia U, Danishefsky K, Traganos F, Darzynkiewicz Z.
    Clin Cancer Res; 1995 Aug 08; 1(8):873-80. PubMed ID: 9816057
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status.
    Syljuåsen RG, Krolewski B, Little JB.
    Cancer Res; 1999 Mar 01; 59(5):1008-14. PubMed ID: 10070956
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dose-dependent effects of DNA-damaging agents on p53-mediated cell cycle arrest.
    Chang D, Chen F, Zhang F, McKay BC, Ljungman M.
    Cell Growth Differ; 1999 Mar 01; 10(3):155-62. PubMed ID: 10099829
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.